ID

36073

Description

Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT02504983

Link

https://clinicaltrials.gov/show/NCT02504983

Keywords

Versions (2)
  1. 4/14/19 4/14/19 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

April 14, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Hepatocellular Carcinoma NCT02504983

English

Eligibility Hepatocellular Carcinoma NCT02504983

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. confirmed diagnosis of hcc:
Description

Liver carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C2239176
cirrhotic subjects: clinical diagnosis by aasld criteria hcc can be defined in cirrhotic subjects by one imaging technique (ct scan, mri, or second generation contrast ultrasound) showing a nodule larger than 2cm with contrast uptake in the arterial phase and washout in venous or late phases, or two imaging techniques showing this radiological behaviour for nodules of 1-2cm in diameter cytohistological confirmation is required for subjects who do not fulfill these eligibility criteria
Description

Study Subject Cirrhotic | Liver carcinoma | Nodule of liver Diameter Imaging Technique | Nodule of liver Diameter CT scan | Nodule of liver Diameter MRI | Nodule of liver Diameter Ultrasonography contrast | Nodule of liver Diameter Imaging Techniques Quantity

Data type

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0439686
UMLS CUI [2]
C2239176
UMLS CUI [3,1]
C0745761
UMLS CUI [3,2]
C1301886
UMLS CUI [3,3]
C0079595
UMLS CUI [4,1]
C0745761
UMLS CUI [4,2]
C1301886
UMLS CUI [4,3]
C0040405
UMLS CUI [5,1]
C0745761
UMLS CUI [5,2]
C1301886
UMLS CUI [5,3]
C0024485
UMLS CUI [6,1]
C0745761
UMLS CUI [6,2]
C1301886
UMLS CUI [6,3]
C0041618
UMLS CUI [6,4]
C0493823
UMLS CUI [7,1]
C0745761
UMLS CUI [7,2]
C1301886
UMLS CUI [7,3]
C0079595
UMLS CUI [7,4]
C1265611
non-cirrhotic subjects:
Description

Study Subject Non-cirrhotic

Data type

boolean

Alias
UMLS CUI [1,1]
C0681850
UMLS CUI [1,2]
C0439687
for subjects without cirrhosis, histological confirmation is mandatory documentation of original biopsy for diagnosis is acceptable
Description

Liver Cirrhosis Absent | Histology Mandatory | Biopsy Acceptable

Data type

boolean

Alias
UMLS CUI [1,1]
C0023890
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0344441
UMLS CUI [2,2]
C1514873
UMLS CUI [3,1]
C0005558
UMLS CUI [3,2]
C1879533
2. never received tace/ chemotherapy/ radiotherapy or targeted agents prior to this study.
Description

TACE Absent | Chemotherapy Absent | Therapeutic radiology procedure Absent | Targeted Therapy Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C3539919
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0332197
UMLS CUI [3,1]
C1522449
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C2985566
UMLS CUI [4,2]
C0332197
3. patients should be either in bclc clinical stage b (multinodular asymptomatic tumors without extra-hepatic spread or portal vein invasion) with or without unilateral secondary or tertiary branches of portal vein invasion. main portal vein invasion or extra-hepatic spread is not allowed.
Description

Hepatocellular Carcinoma by BCLC Stage | Tumor Multinodular Asymptomatic | Spread Extrahepatic Absent | Tumor Cell Invasion Portal vein Absent | Tumor Cell Invasion Portal vein Branch Unilateral | Tumor Cell Invasion Portal vein Branch Unilateral Absent | Tumor Cell Invasion Main portal vein Excluded | Spread Extrahepatic Excluded

Data type

boolean

Alias
UMLS CUI [1]
C3898888
UMLS CUI [2,1]
C0027651
UMLS CUI [2,2]
C0205416
UMLS CUI [2,3]
C0231221
UMLS CUI [3,1]
C0332261
UMLS CUI [3,2]
C1517058
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C1269955
UMLS CUI [4,2]
C1305775
UMLS CUI [4,3]
C0332197
UMLS CUI [5,1]
C1269955
UMLS CUI [5,2]
C1305775
UMLS CUI [5,3]
C1253959
UMLS CUI [5,4]
C0205092
UMLS CUI [6,1]
C1269955
UMLS CUI [6,2]
C1305775
UMLS CUI [6,3]
C1253959
UMLS CUI [6,4]
C0205092
UMLS CUI [6,5]
C0332197
UMLS CUI [7,1]
C1269955
UMLS CUI [7,2]
C1183135
UMLS CUI [7,3]
C0332196
UMLS CUI [8,1]
C0332261
UMLS CUI [8,2]
C1517058
UMLS CUI [8,3]
C0332196
4. child-pugh functional class a or b.
Description

Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1]
C2347612
5. measurable disease using mrecist criteria. at least 1 measurable lesion must be present.
Description

Measurable Disease | Measurable lesion Quantity

Data type

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C1265611
6. ecog performance status 0 to 1.
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
7. age > 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
8. both men and women enrolled in this trial must use adequate birth control measures during the course of the trial and 4 weeks after the completion of trial
Description

Contraceptive methods

Data type

boolean

Alias
UMLS CUI [1]
C0700589
9. informed consent must be obtained prior to study initiation.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
10. total bilirubin < 3.0 mg/dl with no evidence of biliary tract obstruction.
Description

Serum total bilirubin measurement | Biliary tract obstruction Absent

Data type

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2,1]
C0400979
UMLS CUI [2,2]
C0332197
11. serum alanine aminotransferase (alt) and aspartate aminotransferase (ast) < 5 × upper limit of normal.
Description

Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Data type

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
12. absolute neutrophil count > 1000/mm3; platelets ≧ 60x109/l.
Description

Absolute neutrophil count | Platelet Count measurement

Data type

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
13. serum creatinine < 2 x uln.
Description

Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0201976
14. antiviral treatment for hepatitis b or c is allowed except for interferon.
Description

Antiviral Therapy Hepatitis B | Antiviral Therapy Hepatitis C | Exception Interferon

Data type

boolean

Alias
UMLS CUI [1,1]
C0280274
UMLS CUI [1,2]
C0019163
UMLS CUI [2,1]
C0280274
UMLS CUI [2,2]
C0019196
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C3652465
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. bclc stage a.
Description

Hepatocellular Carcinoma by BCLC Stage

Data type

boolean

Alias
UMLS CUI [1]
C3898888
2. presence of extrahepatic metastasis.
Description

Neoplasm Metastasis Extrahepatic

Data type

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C1517058
3. child-pugh score =c
Description

Child-Pugh Classification

Data type

boolean

Alias
UMLS CUI [1]
C2347612
4. significant cardiac disease.
Description

Heart Disease

Data type

boolean

Alias
UMLS CUI [1]
C0018799
5. serious bacteria infection requiring systemic antibiotics.
Description

Bacterial Infection Serious | Requirement Antibiotics for systemic use

Data type

boolean

Alias
UMLS CUI [1,1]
C0004623
UMLS CUI [1,2]
C0205404
UMLS CUI [2,1]
C1514873
UMLS CUI [2,2]
C3540704
6. pregnancy
Description

Pregnancy

Data type

boolean

Alias
UMLS CUI [1]
C0032961
7. expected non-compliance.
Description

Compliance behavior Unlikely

Data type

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0750558
8. uncontrolled illness including, but not limited to, ongoing infection, congestive hear failure, unstable angina pectoris, cardiac arryhythmia, or psychiatric illness.
Description

Illness Uncontrolled | Communicable Disease | Congestive heart failure | Angina, Unstable | Cardiac Arrhythmia | Mental disorders

Data type

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205318
UMLS CUI [2]
C0009450
UMLS CUI [3]
C0018802
UMLS CUI [4]
C0002965
UMLS CUI [5]
C0003811
UMLS CUI [6]
C0004936
9. bleeding esophageal or gastric varices within three months without ligation or sclerosis injection therapy.
Description

Bleeding esophageal varices | Bleeding gastric varices | Ligation Absent | Sclerosis injection therapy Absent

Data type

boolean

Alias
UMLS CUI [1]
C0155789
UMLS CUI [2]
C0267209
UMLS CUI [3,1]
C0023690
UMLS CUI [3,2]
C0332197
UMLS CUI [4,1]
C0036429
UMLS CUI [4,2]
C0444472
UMLS CUI [4,3]
C0332197
10. subjects with known hiv infection.
Description

HIV Infection

Data type

boolean

Alias
UMLS CUI [1]
C0019693
11. ecog status > or = 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Back to the top of the page

Similar models

Eligibility Hepatocellular Carcinoma NCT02504983

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Liver carcinoma
Item
1. confirmed diagnosis of hcc:
boolean
C2239176 (UMLS CUI [1])
Study Subject Cirrhotic | Liver carcinoma | Nodule of liver Diameter Imaging Technique | Nodule of liver Diameter CT scan | Nodule of liver Diameter MRI | Nodule of liver Diameter Ultrasonography contrast | Nodule of liver Diameter Imaging Techniques Quantity
Item
cirrhotic subjects: clinical diagnosis by aasld criteria hcc can be defined in cirrhotic subjects by one imaging technique (ct scan, mri, or second generation contrast ultrasound) showing a nodule larger than 2cm with contrast uptake in the arterial phase and washout in venous or late phases, or two imaging techniques showing this radiological behaviour for nodules of 1-2cm in diameter cytohistological confirmation is required for subjects who do not fulfill these eligibility criteria
boolean
C0681850 (UMLS CUI [1,1])
C0439686 (UMLS CUI [1,2])
C2239176 (UMLS CUI [2])
C0745761 (UMLS CUI [3,1])
C1301886 (UMLS CUI [3,2])
C0079595 (UMLS CUI [3,3])
C0745761 (UMLS CUI [4,1])
C1301886 (UMLS CUI [4,2])
C0040405 (UMLS CUI [4,3])
C0745761 (UMLS CUI [5,1])
C1301886 (UMLS CUI [5,2])
C0024485 (UMLS CUI [5,3])
C0745761 (UMLS CUI [6,1])
C1301886 (UMLS CUI [6,2])
C0041618 (UMLS CUI [6,3])
C0493823 (UMLS CUI [6,4])
C0745761 (UMLS CUI [7,1])
C1301886 (UMLS CUI [7,2])
C0079595 (UMLS CUI [7,3])
C1265611 (UMLS CUI [7,4])
Study Subject Non-cirrhotic
Item
non-cirrhotic subjects:
boolean
C0681850 (UMLS CUI [1,1])
C0439687 (UMLS CUI [1,2])
Liver Cirrhosis Absent | Histology Mandatory | Biopsy Acceptable
Item
for subjects without cirrhosis, histological confirmation is mandatory documentation of original biopsy for diagnosis is acceptable
boolean
C0023890 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0344441 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
C0005558 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
TACE Absent | Chemotherapy Absent | Therapeutic radiology procedure Absent | Targeted Therapy Absent
Item
2. never received tace/ chemotherapy/ radiotherapy or targeted agents prior to this study.
boolean
C3539919 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1522449 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C2985566 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
Hepatocellular Carcinoma by BCLC Stage | Tumor Multinodular Asymptomatic | Spread Extrahepatic Absent | Tumor Cell Invasion Portal vein Absent | Tumor Cell Invasion Portal vein Branch Unilateral | Tumor Cell Invasion Portal vein Branch Unilateral Absent | Tumor Cell Invasion Main portal vein Excluded | Spread Extrahepatic Excluded
Item
3. patients should be either in bclc clinical stage b (multinodular asymptomatic tumors without extra-hepatic spread or portal vein invasion) with or without unilateral secondary or tertiary branches of portal vein invasion. main portal vein invasion or extra-hepatic spread is not allowed.
boolean
C3898888 (UMLS CUI [1])
C0027651 (UMLS CUI [2,1])
C0205416 (UMLS CUI [2,2])
C0231221 (UMLS CUI [2,3])
C0332261 (UMLS CUI [3,1])
C1517058 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C1269955 (UMLS CUI [4,1])
C1305775 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
C1269955 (UMLS CUI [5,1])
C1305775 (UMLS CUI [5,2])
C1253959 (UMLS CUI [5,3])
C0205092 (UMLS CUI [5,4])
C1269955 (UMLS CUI [6,1])
C1305775 (UMLS CUI [6,2])
C1253959 (UMLS CUI [6,3])
C0205092 (UMLS CUI [6,4])
C0332197 (UMLS CUI [6,5])
C1269955 (UMLS CUI [7,1])
C1183135 (UMLS CUI [7,2])
C0332196 (UMLS CUI [7,3])
C0332261 (UMLS CUI [8,1])
C1517058 (UMLS CUI [8,2])
C0332196 (UMLS CUI [8,3])
Child-Pugh Classification
Item
4. child-pugh functional class a or b.
boolean
C2347612 (UMLS CUI [1])
Measurable Disease | Measurable lesion Quantity
Item
5. measurable disease using mrecist criteria. at least 1 measurable lesion must be present.
boolean
C1513041 (UMLS CUI [1])
C1513041 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
ECOG performance status
Item
6. ecog performance status 0 to 1.
boolean
C1520224 (UMLS CUI [1])
Age
Item
7. age > 18 years
boolean
C0001779 (UMLS CUI [1])
Contraceptive methods
Item
8. both men and women enrolled in this trial must use adequate birth control measures during the course of the trial and 4 weeks after the completion of trial
boolean
C0700589 (UMLS CUI [1])
Informed Consent
Item
9. informed consent must be obtained prior to study initiation.
boolean
C0021430 (UMLS CUI [1])
Serum total bilirubin measurement | Biliary tract obstruction Absent
Item
10. total bilirubin < 3.0 mg/dl with no evidence of biliary tract obstruction.
boolean
C1278039 (UMLS CUI [1])
C0400979 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
11. serum alanine aminotransferase (alt) and aspartate aminotransferase (ast) < 5 × upper limit of normal.
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
Absolute neutrophil count | Platelet Count measurement
Item
12. absolute neutrophil count > 1000/mm3; platelets ≧ 60x109/l.
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
Creatinine measurement, serum
Item
13. serum creatinine < 2 x uln.
boolean
C0201976 (UMLS CUI [1])
Antiviral Therapy Hepatitis B | Antiviral Therapy Hepatitis C | Exception Interferon
Item
14. antiviral treatment for hepatitis b or c is allowed except for interferon.
boolean
C0280274 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
C0280274 (UMLS CUI [2,1])
C0019196 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C3652465 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Hepatocellular Carcinoma by BCLC Stage
Item
1. bclc stage a.
boolean
C3898888 (UMLS CUI [1])
Neoplasm Metastasis Extrahepatic
Item
2. presence of extrahepatic metastasis.
boolean
C0027627 (UMLS CUI [1,1])
C1517058 (UMLS CUI [1,2])
Child-Pugh Classification
Item
3. child-pugh score =c
boolean
C2347612 (UMLS CUI [1])
Heart Disease
Item
4. significant cardiac disease.
boolean
C0018799 (UMLS CUI [1])
Bacterial Infection Serious | Requirement Antibiotics for systemic use
Item
5. serious bacteria infection requiring systemic antibiotics.
boolean
C0004623 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1514873 (UMLS CUI [2,1])
C3540704 (UMLS CUI [2,2])
Pregnancy
Item
6. pregnancy
boolean
C0032961 (UMLS CUI [1])
Compliance behavior Unlikely
Item
7. expected non-compliance.
boolean
C1321605 (UMLS CUI [1,1])
C0750558 (UMLS CUI [1,2])
Illness Uncontrolled | Communicable Disease | Congestive heart failure | Angina, Unstable | Cardiac Arrhythmia | Mental disorders
Item
8. uncontrolled illness including, but not limited to, ongoing infection, congestive hear failure, unstable angina pectoris, cardiac arryhythmia, or psychiatric illness.
boolean
C0221423 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2])
C0018802 (UMLS CUI [3])
C0002965 (UMLS CUI [4])
C0003811 (UMLS CUI [5])
C0004936 (UMLS CUI [6])
Bleeding esophageal varices | Bleeding gastric varices | Ligation Absent | Sclerosis injection therapy Absent
Item
9. bleeding esophageal or gastric varices within three months without ligation or sclerosis injection therapy.
boolean
C0155789 (UMLS CUI [1])
C0267209 (UMLS CUI [2])
C0023690 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0036429 (UMLS CUI [4,1])
C0444472 (UMLS CUI [4,2])
C0332197 (UMLS CUI [4,3])
HIV Infection
Item
10. subjects with known hiv infection.
boolean
C0019693 (UMLS CUI [1])
ECOG performance status
Item
11. ecog status > or = 2
boolean
C1520224 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial